Cf Industries Holdings, Inc. CF
We take great care to ensure that the data presented and summarized in this overview for CF Industries Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CF
View all-
Vanguard Group Inc Valley Forge, PA21.4MShares$1.82 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15.9MShares$1.35 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.5MShares$1.06 Billion0.12% of portfolio
-
State Street Corp Boston, MA7.95MShares$676 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA5.57MShares$473 Million0.09% of portfolio
-
Invesco Ltd. Atlanta, GA5.56MShares$473 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA4.44MShares$377 Million0.03% of portfolio
-
First Trust Advisors LP Wheaton, IL4.28MShares$363 Million0.36% of portfolio
-
Victory Capital Management Inc4.19MShares$356 Million0.36% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.13MShares$266 Million0.07% of portfolio
Latest Institutional Activity in CF
Top Purchases
Top Sells
About CF
CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.
Insider Transactions at CF
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 03
2024
|
Susan L Menzel EVP and Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.68%
|
$325,500
$93.0 P/Share
|
Nov 21
2024
|
Ashraf K Malik Sr. VP, Manufacturing & D'istn |
SELL
Open market or private sale
|
Direct |
7,000
-23.96%
|
$630,000
$90.78 P/Share
|
Nov 20
2024
|
Bert A Frost EVP,Sales,MktDev&Supply Chain |
SELL
Open market or private sale
|
Direct |
3,000
-2.83%
|
$264,000
$88.0 P/Share
|
Oct 04
2024
|
Susan L Menzel EVP and Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.93%
|
$180,000
$90.0 P/Share
|
Oct 04
2024
|
Bert A Frost EVP,Sales,MktDev&Supply Chain |
SELL
Open market or private sale
|
Direct |
3,000
-2.75%
|
$270,000
$90.0 P/Share
|
Oct 04
2024
|
Ashraf K Malik Sr. VP, Manufacturing & D'istn |
SELL
Open market or private sale
|
Direct |
7,201
-19.78%
|
$648,090
$90.02 P/Share
|
Jun 17
2024
|
Gregory D Cameron EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
25,270
+41.89%
|
-
|
Jun 17
2024
|
Bert A Frost EVP,Sales,MktDev&Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
45,125
+29.25%
|
-
|
Apr 18
2024
|
Javed Ahmed Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+9.26%
|
-
|
Apr 18
2024
|
Yris Jesus Madrazo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+18.24%
|
-
|
Apr 18
2024
|
Anne P Noonan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+6.17%
|
-
|
Apr 18
2024
|
Michael Toelle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+7.77%
|
-
|
Apr 18
2024
|
Deborah L De Haas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+18.65%
|
-
|
Apr 18
2024
|
Theresa E Wagler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+5.74%
|
-
|
Apr 18
2024
|
Celso L. White Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+9.15%
|
-
|
Apr 18
2024
|
Susan A Ellerbusch Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+34.25%
|
-
|
Apr 18
2024
|
Robert C Arzbaecher Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+2.59%
|
-
|
Apr 18
2024
|
John W Eaves Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,010
+7.77%
|
-
|
Apr 18
2024
|
Stephen J Hagge Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,267
+5.46%
|
-
|
Mar 14
2024
|
Richard A Hoker VP and Corporate Controller |
SELL
Open market or private sale
|
Indirect |
11,029
-22.66%
|
$926,436
$84.11 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 548K shares |
---|---|
Bona fide gift | 10.2K shares |
Payment of exercise price or tax liability | 200K shares |
---|---|
Open market or private sale | 42.7K shares |
Bona fide gift | 15.2K shares |